All Stories

  1. Association of Bach1 Gene Polymorphisms with Susceptibility to Bronchopulmonary Dysplasia in Preterm Infants
  2. Association of hyperglycemia in extremely preterm infants with neurodevelopmental outcomes at 18 months of corrected age
  3. Variability in Home Oxygen Therapy Practices for Bronchopulmonary Dysplasia in Japan: A Questionnaire Survey
  4. Perinatal Risk Factors and Lung Function at 8 Years of Age in Extremely Preterm Infants: Insights from a New Japanese Bronchopulmonary Dysplasia Classification
  5. Impact of Home Oxygen Therapy for Bronchopulmonary Dysplasia on Families With Neonates: A Survey Conducted in Japan
  6. Shifting Paradigms in Bronchopulmonary Dysplasia: From Treatment to Etiology/Pathophysiology-Based Classification
  7. Validation of a New Classification for Severe Bronchopulmonary Dysplasia in Extremely Preterm Infants: Insights from a Large Japanese Cohort
  8. Early Transpyloric Tube Feeding in Preventing Adverse Respiratory Events in Extremely Low Birth Weight Infants
  9. Early Transpyloric Tube Feeding in Preventing Adverse Respiratory Events in Extremely Low Birth Weight Infants
  10. Genetic Ablation of Pyruvate Dehydrogenase Kinase Isoform 4 Gene Enhances Recovery from Hyperoxic Lung Injury: Insights into Antioxidant and Inflammatory Mechanisms
  11. Management of bronchopulmonary dysplasia in Japan: A nationwide survey
  12. Interventions for treating umbilical granuloma: a protocol for a systematic review and meta-analysis of randomised controlled trials
  13. Antenatal corticosteroids in specific groups at risk of preterm birth: a systematic review
  14. School-Age Outcomes of Antenatal Magnesium Sulphate in Preterm Infants
  15. Management and outcomes of periviable neonates born at 22 weeks of gestation: a single-center experience in Japan
  16. Correction To: Increased expression of heme oxygenase-1 suppresses airway branching morphogenesis in fetal mouse lungs exposed to inflammation
  17. iPAPP: study protocol for a multicentre randomised controlled trial comparing safety and efficacy of intravenous paracetamol and indomethacin for the treatment of patent ductus arteriosus in preterm infants
  18. Management and outcomes of periviable neonates born at 22 weeks of gestation: a single-center experience in Japan
  19. Bronchopulmonary Dysplasia in Extremely Premature Infants: A Scoping Review for Identifying Risk Factors
  20. Burden of Treatments for Respiratory Complications in Extremely Premature Infants: Interviews with Caregivers
  21. Therapeutic response of iNO in preterm infants with hypoxemic respiratory failure
  22. Effect of Fentanyl for Preterm Infants on Mechanical Ventilation: A Systematic Review and Meta-Analysis
  23. Oxidative and Inflammatory Markers Are Higher in Full-Term Newborns Suffering Funisitis, and Higher Oxidative Markers Are Associated with Admission
  24. Thioredoxin-1 Ameliorates Oxygen-Induced Retinopathy in Newborn Mice through Modulation of Proinflammatory and Angiogenic Factors
  25. Cytomegalovirus‐related sepsis‐like syndrome in very premature infants in Japan
  26. Is ibuprofen superior to indomethacin for patent ductus arteriosus in Japanese preterm infants?
  27. An experimental animal model of bronchopulmonary dysplasia: Secondary publication
  28. Severe Consumptive Coagulopathy in an Extremely-Low-Birth-Weight Infant with Intra-Abdominal Umbilical Vein Varix: A Case Report
  29. Extreme Prematurity and Pulmonary Outcomes Program in Saitama: Protocol for a Prospective Multicenter Cohort Study in Japan
  30. Impact of being large-for-gestational-age on neonatal mortality and morbidities in extremely premature infants
  31. Branched-chain amino acid supplementation for improving growth and development in term and preterm neonates
  32. Umbilical cord milking versus delayed cord clamping in term infants: a systematic review and meta-analysis
  33. Difference in pyruvic acid metabolism between neonatal and adult mouse lungs exposed to hyperoxia
  34. Extreme Prematurity and Pulmonary Outcomes Program in Saitama: Protocol for a Prospective Multicenter Cohort Study in Japan (Preprint)
  35. Docosahexaenoic acid and bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis
  36. Attenuation of Hyperoxic Lung Injury in Newborn Thioredoxin-1-Overexpressing Mice through the Suppression of Proinflammatory Cytokine mRNA Expression
  37. Increased expression of heme oxygenase-1 suppresses airway branching morphogenesis in fetal mouse lungs exposed to inflammation
  38. Mesenchymal stem cells for the prevention of bronchopulmonary dysplasia
  39. Perinatal factors associated with bubbly/cystic appearance in bronchopulmonary dysplasia: A nationwide, population-based cohort study in Japan
  40. Vitamin A to prevent bronchopulmonary dysplasia in extremely low birth weight infants: a systematic review and meta-analysis
  41. Benefits of umbilical cord milking versus delayed cord clamping on neonatal outcomes in preterm infants: A systematic review and meta-analysis
  42. An in vitro evaluation of the influence of neonatal endotracheal tube diameter and length on the work of breathing
  43. Role of sex in morbidity and mortality of very premature neonates
  44. Bubbly and cystic appearance in chronic lung disease: Is this diagnosed as Wilson–Mikity syndrome?
  45. Sex-related differences in long-term pulmonary outcomes of neonatal hyperoxia in mice
  46. Generation Of Mice With Lung-Specific Expression Of Nuclear Heme Oxygenase-1
  47. Generation of Mice with Lung-specific Expression of Nuclear Heme oxygenase-1
  48. Utility of a new transcutaneous jaundice device with two optical paths in premature infants